Rating History for Hemab Therapeutics Holdings (COAG) by Rodman & Renshaw
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/12/2026 | Michael King Jr. | New Coverage | Buy (N/A) |
56.00 (N/A) |
31.62 (29.94) |
-5.31% | Details |
